XML 35 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Restructuring and Related Activities
 6 Months Ended
Jun. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure Cost Reduction Plan
In early 2025, we announced a plan to reduce our cost structure across operations and selling, general and administrative expenses as we right-size our operations after the sale of our tissue operations (discussed at Note 3). In connection with these activities, we expect to record employee severance costs of $5 to $7 million by the end of 2025. During the quarter and six months ended June 30, 2025, we incurred severance expense of $1 million and $5.1 million associated with this plan. The remaining severance will be recognized from the date of notification until it is earned.
Changes in our severance liability (included in accounts payable and accrued liabilities on the consolidated balance sheet) for the six months ended June 30, 2025 are as follows:
 Total
Balance at December 31, 2024$— 
Employee severance charges included in "other operating charges, net"5.1 
Cost paid or otherwise settled(4.5)
Balance at June 30, 2025$0.5